These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16671571)

  • 1. Effect of nifedipine on cerebral saturation parameters.
    Sal'nikov SN
    Bull Exp Biol Med; 2005 Oct; 140(4):423-4. PubMed ID: 16671571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benidipine hydrochloride--a new calcium-channel blocker of the dihydropyridine type. Pharmacokinetics, pharmacodynamics, tolerance and dose finding in mild to moderate hypertension.
    Maier-Lenz H; Rode H; Lenau H; Thieme G; Wölke E; Kobayashi H; Kobayashi S; Oka T
    Arzneimittelforschung; 1988 Nov; 38(11A):1757-63. PubMed ID: 3219156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of nifedipine controlled release on blood pressure and heart rate of spontaneously hypertensive rats. Comparison with nifedipine standard and with amlodipine].
    Di Filippo C; Lampa E; Forgione A; Capuano A; Rossi F; D'Amico M
    Ital Heart J Suppl; 2005 May; 6(5):285-90. PubMed ID: 15934425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nifedipine on superior mesenteric artery impedance in humans.
    Voet D; Mareels S; Duprez D; De Buyzere M; Afschrift M; Clement DL
    Eur J Clin Pharmacol; 1996; 51(1):39-43. PubMed ID: 8880049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension.
    Diamond JA; Krakoff LR; Goldman A; Coplan N; Gharavi A; Martin K; Goldsmith R; Henzlova MJ; Machac J; Phillips RA
    Am J Hypertens; 2001 Mar; 14(3):231-40. PubMed ID: 11281234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nilvadipine on cerebral circulation and metabolism in cats.
    Isozumi K; Izumi Y; Fukuuchi Y; Gotoh F
    Arzneimittelforschung; 1990 Apr; 40(4):421-4. PubMed ID: 2113386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties.
    Grundy JS; Foster RT
    Clin Pharmacokinet; 1996 Jan; 30(1):28-51. PubMed ID: 8846626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses.
    Tröger U; Martens J; Meyer FP; Hoffmann A; Terhaag B
    Arzneimittelforschung; 1995 Dec; 45(12):1266-70. PubMed ID: 8595082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympathoinhibitory effects of central nifedipine in spontaneously hypertensive rats on high versus regular sodium intake.
    Huang BS; Leenen FH
    Hypertension; 1999 Jan; 33(1):32-5. PubMed ID: 9931078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nifedipine in ischemic heart disease.
    Kloner RA
    Circulation; 1995 Sep; 92(5):1074-8. PubMed ID: 7648647
    [No Abstract]   [Full Text] [Related]  

  • 12. Vasodilating effects of the new calcium antagonist benidipine hydrochloride in anesthetized dogs and cats.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1707-12. PubMed ID: 3219145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of two dihydropyridine calcium antagonists in humans.
    Belz GG; Bliesath H; Essig J; Neumann N; Zech K; Wurst W
    Clin Pharmacol Ther; 1992 Jul; 52(1):68-79. PubMed ID: 1623694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacodynamics and pharmacokinetics of a new calcium antagonist nisoldipine in normotensive and hypertensive subjects.
    Pasanisi F; Meredith PA; Reid JL
    Eur J Clin Pharmacol; 1985; 29(1):21-4. PubMed ID: 4054203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical consequences of the absorption, distribution, metabolism and excretion of amlodipine.
    Elliott HL; Meredith PA
    Postgrad Med J; 1991; 67 Suppl 3():S20-3. PubMed ID: 1836870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of renal function on the pharmacokinetics and cardiovascular effects of nisoldipine after single and multiple dosing.
    van Harten J; Burggraaf J; van Brummelen P; Breimer DD
    Clin Pharmacokinet; 1989 Jan; 16(1):55-64. PubMed ID: 2706880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vasodilator effects of LF 2.0254, a new 1,4-dihydropyridine. Comparison with nifedipine].
    Pruneau D; Roy F; Brown NL
    Therapie; 1989; 44(3):203-8. PubMed ID: 2781506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium blockers and risk of myocardial infarction and coronary heart disease mortality.
    Mehta JL; Subramanian VB
    Circulation; 1996 Apr; 93(7):1472; author reply 1473. PubMed ID: 8641039
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics and hemodynamic effects of nisoldipine and its interaction with cimetidine.
    van Harten J; van Brummelen P; Lodewijks MT; Danhof M; Breimer DD
    Clin Pharmacol Ther; 1988 Mar; 43(3):332-41. PubMed ID: 3345623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of nifedipine. Implications for the care of the elderly.
    Elliott HL; Meredith PA
    Drugs Aging; 1997 Dec; 11(6):470-9. PubMed ID: 9413704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.